This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ma, J. Articles by Tompkins, W. A. Search for Related Content PubMed PubMed Citation Articles by Ma, J. Articles by Tompkins, W. A.

 Previous Article  |  Next Article 

Journal of Virology, October 2002, p. 9952-9961, Vol. 76, No. 19
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.19.9952-9961.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Inhibitory Activity of Synthetic Peptide Antibiotics on Feline Immunodeficiency Virus Infectivity In Vitro

Jia Ma,^1* Suzanne Kennedy-Stoskopf,¹ Jesse M. Jaynes,² Linda M. Thurmond,³ and Wayne A. Tompkins¹

Department of Microbiology, Pathology and Parasitology, North Carolina State University, Raleigh, North Carolina,¹ Demegen, Inc., Pittsburgh, Pennsylvania,² Glaxo SmithKline Inc., Research Triangle Park, North Carolina³

Received 25 January 2002/ Accepted 14 June 2002

Natural peptide antibiotics are part of host innate immunity against a wide range of microbes, including some viruses. Synthetic peptides modeled after natural peptide antibiotics interfere with microbial membranes and are termed peptidyl membrane-interactive molecules (peptidyl-MIM [Demegen Inc, Pittsburgh, Pa.]). Sixteen peptidyl-MIM candidates were tested for activity against feline immunodeficiency virus (FIV) on infected CrFK cells. Three of them (D4E1, DC1, and D1D6) showed potent anti-FIV activity in chronically infected CrFK cells as measured by decreased reverse transcriptase (RT) activity, having 50% inhibitory concentrations of 0.46, 0.75, and 0.94 µM, respectively, which were approximately 10 times lower than their direct cytotoxic concentrations. Treatment of chronically infected CrFK cells with 2 µM D4E1 for 3 days completely reversed virus-induced cytopathic effect. Immunofluorescence revealed reduced p26 staining in these cells. Treatment of chronically infected CrFK cells with 2 µM D4E1 suppressed virus production (50%) for up to 7 days, The virions from the D4E1-treated culture had impaired infectivity, as measured by the 50% tissue culture infectious dose and nested PCR analysis of proviral DNA. However, these noninfectious virions were able to bind and internalize, suggesting a defect at some postentry step. After chronically infected CrFK cells were treated with D4E1 for 24 h, increased cell-associated mature p26 Gag and decreased extracellular virus-associated p26 Gag were observed by Western blot analysis, suggesting that virus assembly and/or release may be blocked by D4E1 treatment, whereas virus binding, penetration, RNA synthesis, and protein synthesis appear to be unaffected. Synthetic peptide antibiotics may be useful tools in the search for antiviral drugs having a wide therapeutic window for host cells.

---

* Corresponding author. Present address: Glaxo SmithKline, EH.A2217C.2G, 5 Moore Dr., Research Triangle Park, NC 27709. Phone: (919) 483-8440. Fax: (919) 315-6003. E-mail: jzm83081{at}gsk.com.

---

Journal of Virology, October 2002, p. 9952-9961, Vol. 76, No. 19
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.19.9952-9961.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Joshi, A., Garg, H., Tompkins, M. B., Tompkins, W. A. (2005). Preferential Feline Immunodeficiency Virus (FIV) Infection of CD4+ CD25+ T-Regulatory Cells Correlates both with Surface Expression of CXCR4 and Activation of FIV Long Terminal Repeat Binding Cellular Transcriptional Factors. J. Virol. 79: 4965-4976 [Abstract] [Full Text]